Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study.
Bavaro DF, Belati A, Diella L, Frallonardo L, Guido G, Papagni R, Pellegrino C, Brindicci G, De Gennaro N, Di Gennaro F, Denicolò S, Ronga L, Mosca A, Pomarico F, Dell'Aera M, Stufano M, Dalfino L, Grasso S, Saracino A. Bavaro DF, et al. Among authors: brindicci g. J Antimicrob Chemother. 2023 Sep 5;78(9):2175-2184. doi: 10.1093/jac/dkad215. J Antimicrob Chemother. 2023. PMID: 37428015
High risk of unsuccessful treatment outcome in migrant population with tuberculosis: Data from three Italian hospitals.
Di Gennaro F, Cotugno S, Fasano M, Ricciardi A, Ronga L, Lattanzio R, Grimaldi A, Bavaro DF, Ciarallo M, Garzone S, De Iaco G, Guido G, Fiore JR, Brindicci G, Santoro CR, Sica S, Iacovazzi TL, Santantonio TA, Saracino A. Di Gennaro F, et al. Among authors: brindicci g. Front Public Health. 2023 Jan 10;10:1024474. doi: 10.3389/fpubh.2022.1024474. eCollection 2022. Front Public Health. 2023. PMID: 36703820 Free PMC article.
Use of Sotrovimab in a cohort of pregnant women with a high risk of COVID 19 progression: a single-center experience.
Frallonardo L, Vimercati A, Novara R, Lepera C, Ferrante I, Chiarello G, Cicinelli R, Mongelli M, Brindicci G, Segala FV, Santoro CR, Bavaro DF, Laforgia N, Cicinelli E, Saracino A, Di Gennaro F. Frallonardo L, et al. Among authors: brindicci g. Pathog Glob Health. 2023 Jul;117(5):513-519. doi: 10.1080/20477724.2023.2188839. Epub 2023 Mar 10. Pathog Glob Health. 2023. PMID: 36896940 Free PMC article.
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study.
Veronese N, Segala FV, Carruba L, La Carrubba A, Pollicino F, Di Franco G, Guido G, Cormio M, Lugli A, De Santis L, Guerra V, Pepe M, Tritto R, Ciccone MM, Bavaro DF, Brindicci G, Mansueto P, Giannitrapani L, Di Gennaro F, Barbagallo M, Saracino A. Veronese N, et al. Among authors: brindicci g. Sci Rep. 2023 Jun 3;13(1):9035. doi: 10.1038/s41598-023-36208-y. Sci Rep. 2023. PMID: 37270578 Free PMC article.
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study.
Bavaro DF, Papagni R, Belati A, Diella L, De Luca A, Brindicci G, De Gennaro N, Di Gennaro F, Romanelli F, Stolfa S, Ronga L, Mosca A, Pomarico F, Dell'Aera M, Stufano M, Dalfino L, Grasso S, Saracino A. Bavaro DF, et al. Among authors: brindicci g. Infect Dis Ther. 2023 Aug;12(8):2147-2163. doi: 10.1007/s40121-023-00854-6. Epub 2023 Sep 1. Infect Dis Ther. 2023. PMID: 37653122 Free PMC article.
Stigma and mental health among people living with HIV across the COVID-19 pandemic: a cross-sectional study.
Di Gennaro F, Papagni R, Segala FV, Pellegrino C, Panico GG, Frallonardo L, Diella L, Belati A, Santoro CR, Brindicci G, Balena F, Bavaro DF, Montalbò D, Guido G, Calluso L, Di Tullio M, Sgambati M, Fiordelisi D, De Gennaro N, Saracino A. Di Gennaro F, et al. Among authors: brindicci g. BMC Infect Dis. 2024 Apr 22;24(1):423. doi: 10.1186/s12879-024-09315-y. BMC Infect Dis. 2024. PMID: 38649892 Free PMC article.
Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis.
Veronese N, Di Gennaro F, Frallonardo L, Ciriminna S, Papagni R, Carruba L, Agnello D, De Iaco G, De Gennaro N, Di Franco G, Naro L, Brindicci G, Rizzo A, Bavaro DF, Garlisi MC, Santoro CR, Signorile F, Balena F, Mansueto P, Milano E, Giannitrapani L, Fiordelisi D, Mariani MF, Procopio A, Lattanzio R, Licata A, Vernuccio L, Amodeo S, Guido G, Segala FV, Barbagallo M, Saracino A. Veronese N, et al. Among authors: brindicci g. Sci Rep. 2024 Apr 23;14(1):9303. doi: 10.1038/s41598-024-59957-w. Sci Rep. 2024. PMID: 38654033 Free PMC article.
Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study.
Belati A, Diella L, Bavaro DF, De Santis L, Cotugno S, De Gennaro N, Brindicci G, Maggiore ME, Indraccolo F, Di Gennaro F, Ronga L, Mosca A, Stufano M, Dalfino L, Grasso S, Saracino A. Belati A, et al. Among authors: brindicci g. Int J Antimicrob Agents. 2024 Aug;64(2):107247. doi: 10.1016/j.ijantimicag.2024.107247. Epub 2024 Jun 19. Int J Antimicrob Agents. 2024. PMID: 38906485
Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021.
Bergna A, Lai A, Ventura CD, Bruzzone B, Weisz A, d'Avenia M, Testa S, Torti C, Sagnelli C, Menchise A, Brindicci G, Francisci D, Vicenti I, Clementi N, Callegaro A, Rullo EV, Caucci S, De Pace V, Orsi A, Brusa S, Greco F, Letizia V, Vaccaro E, Franci G, Rizzo F, Sagradi F, Lanfranchi L, Coppola N, Saracino A, Sampaolo M, Ronchiadin S, Galli M, Riva A, Zehender G; SARS-CoV-2 ITALIAN RESEARCH ENTERPRISE - (SCIRE) collaborative Group. Bergna A, et al. Among authors: brindicci g. J Med Virol. 2023 Nov;95(11):e29193. doi: 10.1002/jmv.29193. J Med Virol. 2023. PMID: 37927140 Free article.
Latent tuberculosis infection detected by quantiferon-TB assay in patients with multiple myeloma receiving novel drugs: focus on reactivation prophylaxis in a retrospective, single-center study.
Sgherza N, Curci P, Brindicci G, Capozzi A, Di Carlo G, Grande D, Brescia V, Rossi AR, Musto P. Sgherza N, et al. Among authors: brindicci g. Ann Hematol. 2024 Aug;103(8):3251-3253. doi: 10.1007/s00277-024-05784-y. Epub 2024 May 4. Ann Hematol. 2024. PMID: 38702445 No abstract available.
111 results